Tonix Pharmaceuticals Holding Corp. conducted its annual meeting of shareholders on May 8, 2025. Shareholders approved several proposals during the meeting. Eight individuals were elected to the Board of Directors. The amendment to the Company's Amended and Restated Stock 2020 Stock Incentive Plan, increasing the number of shares available for awards, was approved. The 2025 Employee Stock Purchase Plan received approval. The authorization for the Board of Directors to effect one or more reverse stock splits within a specified range was also approved. Additionally, the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。